The Patent Finder

MD Bioalpha Co., Ltd.

Also on record
Records under this name other than patents MD Bioalpha Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to MD Bioalpha Co., Ltd.

PatentTitleStatus Expires Confidence
US 9,066,922Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
Formerly held
Term ended
Term ended Feb 15, 2026 · From the USPTO record
Term endedTerm ended Feb 15, 2026From the USPTO record
US 8,029,832Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
Formerly held
Lapsed on the fee record
Ended Oct 4, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 4, 2023From the USPTO record
US 8,466,141Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
Formerly held
Lapsed on the fee record
Ended Jun 18, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 18, 2021From the USPTO record
US 7,375,243Method for preparation of amino acid chelate
Formerly held
Lapsed on the fee record
Ended May 20, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2020From the USPTO record
US 7,901,716Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
Formerly held
Lapsed on the fee record
Ended Mar 8, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited